Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta− analysis

BACKGROUND: Traditional Chinese patent medicines (TCPMs) have been widely used to treat carotid atherosclerotic plaque (CAP) in China. However, systematic evaluation of the clinical efficacy of TCPMs for CAP is still unknown, and the comparative efficacy of different TCPMs is unclear. OBJECTIVES: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Wenquan, Xie, Xiaolong, Zhao, Jiping, Fan, Qinhua, Dong, Naijia, Li, Qingxiao, Du, Yawei, Wu, Shengxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662928/
https://www.ncbi.nlm.nih.gov/pubmed/37986011
http://dx.doi.org/10.1186/s13020-023-00850-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662928/
https://www.ncbi.nlm.nih.gov/pubmed/37986011
http://dx.doi.org/10.1186/s13020-023-00850-5

Ejemplares similares